FDA Drug recall N/A
Tri-Immune Boost (Glutathione: 200 mg, Ascorbic Acid: 200 mg, Zinc: 2.5 mg), 30 mL vial, Rx only, Centric Compounding, 7447 Harwin Dr. Suit…
- FDA Drug
- ongoing
- Published 2026-10-14
On 2026-10-14 the FDA announced a recall of Tri-Immune Boost (Glutathione: 200 mg, Ascorbic Acid: 200 mg, Zinc: 2.5 mg), 30 mL vial, Rx only, Centric Compounding, 7447 Harwin Dr. Suit… by Centric Compounding, citing microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | N/A |
| Classification | Not classified |
| Status | ongoing |
| Initiated | 2026-07-27 |
| Published | 2026-10-14 |
| Last updated | 2026-10-21 05:30 UTC |
| Company | Centric Compounding |
| Distribution | US |
Product
Tri-Immune Boost (Glutathione: 200 mg, Ascorbic Acid: 200 mg, Zinc: 2.5 mg), 30 mL vial, Rx only, Centric Compounding, 7447 Harwin Dr. Suite 111, Houston, TX 77036
Reason
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Identifiers
| code_info | Lot #: 071626:B, Beyond Use Date: 8/30/26 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22N%2FA%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.